Characterization of a soft-tissue infection model in the horse and its response to intravenous cephapirin administration.

The research identifies and examines reactions of horses to soft-tissue infections, specifically from Streptococcus zooepidemicus organisms, and tests the effectiveness of intravenous cephapirin in treating these. The study reveals that while cephapirin alleviates symptoms and lessens bacterial count, it did not fully eliminate the infection.

Objective of the Study

• The purpose of this investigation was to create a model of a soft-tissue infection in horses by infecting the subcutaneous tissue chambers with Streptococcus zooepidemicus bacteria.
• Another objective was to understand the reactions the horses had to the given infections and evaluate the efficacy of using intravenous cephapirin to treat such infections.

Methodology

• The team monitored changes in the horses’ complete blood count, body temperature, cytology, and protein content of tissue chambers to determine their reactions to the infection.
• Once the infections were established, four out of the eight horses were treated with intravenous cephapirin at a dosage of 20 mg/kg for a period of 5 days.
• Quantitative culture of the tissue chamber fluid was carried out to analyze the effect of cephapirin treatment.

Findings

• Systemic reactions to the infections included mild neutrophilia (an abnormal increase in the number of neutrophils), pyrexia (fever), and mild anemia.
• There was a significant entry of neutrophils and protein into the tissue chambers after they were infected with bacteria. Additionally, the viability of neutrophils in the chambers decreased significantly during the peak infection period.
• Post cephapirin treatment there were reductions in systemic neutrophilia, pyrexia, anemia, and bacterial counts in the tissue chambers.

Conclusion

• While it was observed that cephapirin therapy resulted in a substantial improvement in the horses’ condition, it failed to completely eliminate the infection from any of the chambers. However, it was found that the viability of neutrophils in the chamber significantly increased during the cephapirin treatment period.